Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas

被引:2
|
作者
Machuca-Aguado, Jesus [1 ,2 ]
Conde-Martin, Antonio Felix [1 ,2 ]
Alvarez-Munoz, Alejandro [1 ,2 ]
Rodriguez-Zarco, Enrique [1 ,2 ]
Polo-Velasco, Alfredo [2 ,3 ]
Rueda-Ramos, Antonio [2 ,4 ]
Rendon-Garcia, Rosa [1 ,2 ]
Rios-Martin, Juan Jose [1 ,2 ]
Idoate, Miguel A. [1 ,2 ]
机构
[1] Univ Seville, Virgen Macarena Univ Hosp, Dept Pathol, Seville 41009, Spain
[2] Univ Seville, Sch Med, Seville 41009, Spain
[3] Univ Seville, Virgen Macarena Univ Hosp, Gynecol Dept, Seville 41009, Spain
[4] Univ Seville, Virgen Macarena Univ Hosp, Oncol Dept, Seville 41009, Spain
关键词
ovarian cancer; tumor-infiltrating lymphocytes; digital quantification; algorithms; machine learning; T-CELLS; IMMUNOTHERAPY; PD-1/PD-L1; EXPRESSION; BRCA1; TILS;
D O I
10.3390/ijms242216060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prognostic and predictive role of tumor-infiltrating lymphocytes (TILs) has been demonstrated in various neoplasms. The few publications that have addressed this topic in high-grade serous ovarian carcinoma (HGSOC) have approached TIL quantification from a semiquantitative standpoint. Clinical correlation studies, therefore, need to be conducted based on more accurate TIL quantification. We created a machine learning system based on H&E-stained sections using 76 molecularly and clinically well-characterized advanced HGSOC. This system enabled immune cell classification. These immune parameters were subsequently correlated with overall survival (OS) and progression-free survival (PFI). An intense colonization of the tumor cords by TILs was associated with a better prognosis. Moreover, the multivariate analysis showed that the intraephitelial (ie) TILs concentration was an independent and favorable prognostic factor both for OS (p = 0.02) and PFI (p = 0.001). A synergistic effect between complete surgical cytoreduction and high levels of ieTILs was evidenced, both in terms of OS (p = 0.0005) and PFI (p = 0.0008). We consider that digital analysis with machine learning provided a more accurate TIL quantification in HGSOC. It has been demonstrated that ieTILs quantification in H&E-stained slides is an independent prognostic parameter. It is possible that intraepithelial TIL quantification could help identify candidate patients for immunotherapy.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma
    Hamada, Kohei
    Murakami, Ryusuke
    Ueda, Akihiko
    Kashima, Yoko
    Miyagawa, Chiho
    Taki, Mana
    Yamanoi, Koji
    Yamaguchi, Ken
    Hamanishi, Junzo
    Minamiguchi, Sachiko
    Matsumura, Noriomi
    Mandai, Masaki
    AMERICAN JOURNAL OF PATHOLOGY, 2024, 194 (07) : 1272 - 1284
  • [2] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Farrag, Mayada Saad
    Abdelwahab, Khaled
    Farrag, Nesrine Saad
    Elrefaie, Waleed Elsayed
    Emarah, Ziad
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2021, 33 (01)
  • [3] Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
    Dai, Danian
    Liu, Lili
    Huang, He
    Chen, Shangqiu
    Chen, Bo
    Cao, Junya
    Luo, Xiaolin
    Wang, Feng
    Luo, Rongzhen
    Liu, Jihong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Prognostic impact of tumor-infiltrating lymphocytes in high grade serous ovarian cancer: a systematic review and meta-analysis
    Hao, Jiatao
    Yu, Hui
    Zhang, Taohong
    An, Ruifang
    Xue, Yan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [5] PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
    Chen, Hao
    Molberg, Kyle
    Strickland, Amanda L.
    Castrillon, Diego H.
    Carrick, Kelley
    Jiang, Qingping
    Niu, Shuang
    Rivera-Colon, Glorimar
    Gwin, Katja
    Hinson, Stacy
    Lea, Jayanthi
    Miller, David S.
    Zheng, Wenxin
    Lucas, Elena
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (08) : 1050 - 1060
  • [6] Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review
    Chen, F.
    Gaitskell, K.
    Garcia, M. J.
    Albukhari, A.
    Tsaltas, J.
    Ahmed, A. A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (06) : 872 - 878
  • [7] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Mayada Saad Farrag
    Khaled Abdelwahab
    Nesrine Saad Farrag
    Waleed Elsayed Elrefaie
    Ziad Emarah
    Journal of the Egyptian National Cancer Institute, 33
  • [8] The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer
    Belotti, Yuri
    Lim, Elaine Hsuen
    Lim, Chwee Teck
    CANCERS, 2022, 14 (02)
  • [9] The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
    Li, Jun
    Wang, Jieyu
    Chen, Ruifang
    Bai, Yang
    Lu, Xin
    ONCOTARGET, 2017, 8 (09) : 15621 - 15631
  • [10] Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
    Goode, Ellen L.
    Block, Matthew S.
    Kalli, Kimberly R.
    Vierkant, Robert A.
    Chen, Wenqian
    Fogarty, Zachary C.
    Gentry-Maharaj, Aleksandra
    Toloczko, Aleksandra
    Hein, Alexander
    Bouligny, Aliecia L.
    Jensen, Allan
    Osorio, Ana
    Hartkopf, Andreas D.
    Ryan, Andy
    Chudecka-Glaz, Anita
    Magliocco, Anthony M.
    Hartmann, Arndt
    Jung, Audrey Y.
    Gao, Bo
    Hernandez, Brenda Y.
    Fridley, Brooke L.
    McCauley, Bryan M.
    Kennedy, Catherine J.
    Wang, Chen
    Karpinskyj, Chloe
    de Sousa, Christiani B.
    Tiezzi, Daniel G.
    Wachter, David L.
    Herpel, Esther
    Taran, Florin Andrei
    Modugno, Francesmary
    Nelson, Gregg
    Lubinski, Jan
    Menkiszak, Janusz
    Alsop, Jennifer
    Lester, Jenny
    Garcia-Donas, Jesus
    Nation, Jill
    Hung, Jillian
    Palacios, Jose
    Rothstein, Joseph H.
    Kelley, Joseph L.
    de Andrade, Jurandyr M.
    Robles-Diaz, Luis
    Intermaggio, Maria P.
    Widschwendter, Martin
    Beckmann, Matthias W.
    Ruebner, Matthias
    Jimenez-Linan, Mercedes
    Singh, Naveena
    JAMA ONCOLOGY, 2017, 3 (12)